Fungal / Candida
1. Root Cause Overview
Candida albicans and other fungal species are commensal organisms of the human gut, oral cavity, and urogenital tract. Overgrowth occurs when the ecological balance is disrupted by antibiotics, immunosuppression, high-sugar diets, or gut dysbiosis. Systemic candidiasis is a serious medical emergency in immunocompromised patients; however, subclinical intestinal fungal overgrowth is common and contributes to gut dysbiosis, intestinal permeability, food sensitivities, and systemic symptoms. Candida produces over 70 toxic metabolites including acetaldehyde, which impairs mitochondrial function and contributes to fatigue and brain fog.
2. Common Signs & Symptoms
- Recurrent oral thrush or vaginal yeast infections
- Intense sugar and carbohydrate cravings
- Brain fog and cognitive impairment
- Chronic fatigue
- Bloating and gas, particularly after carbohydrate intake
- Skin conditions: athlete's foot, nail fungal infections, jock itch
- Recurrent sinusitis or nasal congestion
- Mood disturbances: depression, anxiety, irritability
- Elevated arabinose on organic acid testing
- Food sensitivities (particularly to yeast-containing foods)
3. Labs to Consider
CBC (eosinophilia), stool culture when available, vaginal/oral swab for symptomatic areas.
Choose the lab option based on what you want to assess within this root cause.
Organic Acid Test (OAT)
Mosaic Diagnostics
4. Clinical Priorities
Assess for factors that may be promoting fungal overgrowth, including high sugar intake, recent antibiotic or steroid use, immune suppression, dysbiosis, poor glycaemic control, and impaired gut barrier function. Confirm fungal overgrowth with objective testing when possible before initiating antifungal protocols. A phased approach may still be useful: reduce fungal burden, support the gut barrier, and reintroduce beneficial flora as tolerated, while managing die-off reactions by introducing antifungal agents gradually.
Where to Start: Top 2 Supplements
The most specific and well-evidenced natural antifungal agent. Disrupts Candida cell membrane integrity and inhibits biofilm formation. Derived from coconut oil, it is well-tolerated and can be used as a first-line antifungal alongside dietary intervention. Start low to manage die-off reactions.
Provides competitive exclusion of Candida in the GI tract, restores gut barrier function, and supports sIgA — the primary mucosal defence against fungal overgrowth. Antibiotic-resistant and safe to use alongside antifungal agents. Essential for the re-inoculation phase after antifungal treatment.
5. Diet Strategy
Implement an anti-Candida diet (4–8 weeks): eliminate all sugars (including fruit initially), refined carbohydrates, alcohol, vinegar, fermented foods (temporarily), and yeast-containing foods. Emphasise non-starchy vegetables, clean proteins, healthy fats, and low-sugar berries. Garlic, coconut oil (caprylic acid), and apple cider vinegar have antifungal properties. After treatment phase, gradually reintroduce prebiotic foods to restore microbiome balance.
6. Lifestyle Strategy
Manage blood sugar — hyperglycaemia promotes Candida growth. Wear breathable clothing and maintain good hygiene in skin fold areas. Avoid unnecessary antibiotics and corticosteroids. Manage stress — cortisol suppresses immune surveillance of Candida. Ensure adequate sleep. Avoid swimming in chlorinated pools during active treatment. Probiotics should be taken during and after antifungal treatment to restore bacterial competition.
7. Supplement Strategy
Full supplement list below. See Section 4 (Clinical Priorities) for the recommended Top 2 starting supplements. Add additional supplements based on lab results and clinical response at 4–6 week reassessment.
| Supplement | Dosage | Indication | Evidence | Key Results | Example |
|---|---|---|---|---|---|
| Caprylic Acid (from coconut oil) [1] GI upset, nausea; die-off reactions (Herxheimer) — start low; avoid in inflammatory bowel disease | 1,000–2,000 mg TID with meals | Antifungal activity against Candida; disrupts fungal cell membrane integrity | In vitro and animal studies | Effective inhibition of Candida albicans growth; disruption of fungal biofilm formation | Designs for Health Caprylic Acid |
| Oregano Oil (Origanum vulgare, standardised to carvacrol) [2] GI irritation; avoid in pregnancy; use short-term with probiotic support | 200 mg BID (≥55% carvacrol) | Broad-spectrum antifungal; Candida biofilm disruption; antimicrobial | In vitro and clinical studies | Effective against multiple Candida species including fluconazole-resistant strains; disrupts biofilm formation | Nutricology Oregano Oil |
| Saccharomyces boulardii [3] Avoid in immunocompromised patients; generally well tolerated | 5–10 billion CFU/day | Competitive exclusion of Candida; gut microbiome restoration; sIgA support | In vitro and clinical studies | Reduced Candida colonisation in GI tract; improved gut barrier function; restored microbiome balance | Jarrow Formulas Saccharomyces Boulardii + MOS |
| Berberine [4] GI upset; contraindicated in pregnancy; CYP3A4 interactions | 500 mg TID | Antifungal and antimicrobial activity; gut microbiome rebalancing; anti-biofilm | In vitro studies | Inhibited Candida albicans growth and biofilm formation; reduced virulence factors | Thorne Berberine-500 |
| Biotin (high-dose) [5] Generally well tolerated; interferes with biotin-based lab assays (thyroid, troponin) — disclose to lab | 1,000–8,000 mcg/day | Inhibits Candida morphological switching from yeast to invasive hyphal form | In vitro studies | High-dose biotin inhibited Candida albicans conversion to hyphal form, reducing invasiveness | Pure Encapsulations Biotin |
8. Safety Notes
Do not treat suspected systemic candidiasis with supplements — this is a medical emergency requiring prescription antifungal therapy (fluconazole, amphotericin B). Die-off reactions (Herxheimer) can cause significant symptom flares — start antifungal agents slowly and support detox pathways. High-dose biotin interferes with multiple laboratory assays — always inform the laboratory. Refer for recurrent or severe candidiasis, particularly in immunocompromised patients.
9. Citations & References
- [1]Caprylic Acid (from coconut oil)Bergsson G, Arnfinnsson J, Steingrímsson Ó, Thormar H. In vitro killing of Candida albicans by fatty acids and monoglycerides. Antimicrob Agents Chemother. 2001;45(11):3209–3212.View source
- [2]Oregano Oil (Origanum vulgare, standardised to carvacrol)Manohar V, Ingram C, Gray J, et al. Antifungal activities of origanum oil against Candida albicans. Mol Cell Biochem. 2001;228(1–2):111–117.View source
- [3]Saccharomyces boulardiiMurzyn A, Krasowska A, Stefanowicz P, Dziadkowiec D, Łukaszewicz M. The effect of Saccharomyces boulardii on Candida albicans-infected human intestinal cell lines Caco-2 and intestinal epithelium. FEMS Microbiol Lett. 2010;310(1):17–23.View source
- [4]BerberineImenshahidi M, Hosseinzadeh H. Berberis vulgaris and berberine: an update review. Phytother Res. 2016;30(11):1745–1764.View source
- [5]Biotin (high-dose)Bonjour JP. Biotin in man's nutrition and therapy — a review. Int J Vitam Nutr Res. 1977;47(2):107–118.View source
Ask AI About This Protocol
Related Mini-Training
12:18Functional Gastroenterology Quick Start
9:47SIBO: Causes, Testing & Treatment
10:15Anti-Inflammatory Nutrition